Your browser doesn't support javascript.
loading
Evidence of a clinically significant drug-drug interaction between cannabidiol and tacrolimus.
Leino, Abbie D; Emoto, Chie; Fukuda, Tsuyoshi; Privitera, Michael; Vinks, Alexander A; Alloway, Rita R.
Afiliação
  • Leino AD; Division of Nephrology, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio.
  • Emoto C; Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
  • Fukuda T; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio.
  • Privitera M; Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
  • Vinks AA; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio.
  • Alloway RR; Department of Neurology & Rehabilitation Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio.
Am J Transplant ; 19(10): 2944-2948, 2019 10.
Article em En | MEDLINE | ID: mdl-31012522

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Canabidiol / Tacrolimo / Epilepsia / Imunossupressores / Nefrite Intersticial Tipo de estudo: Prognostic_studies Limite: Adult / Female / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Canabidiol / Tacrolimo / Epilepsia / Imunossupressores / Nefrite Intersticial Tipo de estudo: Prognostic_studies Limite: Adult / Female / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article